Wolfram; Swen

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wolfram; Swen.The latest application filed is for "treating conditions associated with increased eotaxin with 25-hydroxyvitamin d3".

Company Profile

0.8.39

Wolfram; Swen - Basel CH
WOLFRAM; Swen - Waldshut-Tiengen DE
Wolfram; Swen - Waldschut-Tiengen DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Treating conditions associated with increased eotaxin with 25-hydroxyvitamin D3 Grant 10,357,501 - Krammer-Lukas , et al. July 23, 2	2019-07-23
Treating Conditions Associated With Increased Eotaxin With 25-hydroxyvitamin D3 App 20170106005 - KRAMMER-LUKAS; Stephanie ; et al.	2017-04-20
Combination Of Vitamin D And 25-hydroxyvitamin D 3 App 20160324877 - BUCK; Neil Robert ; et al.	2016-11-10
Use Of 25-hydroxy-vitamin D3 To Affect Human Muscle Physiology App 20160263128 - BUCK; Neil Robert ; et al.	2016-09-15
Trigonelline as a muscle stimulant Grant 9,241,938 - Friedel , et al. January 26, 2	2016-01-26
Trigonelline As A Muscle Stimulant App 20150079206 - FRIEDEL; Angelika ; et al.	2015-03-19
Niacin and/or trigonelline as a muscle stimulant Grant 8,772,230 - Friedel , et al. July 8, 2	2014-07-08
Treating Conditions Associated With Increased Eotaxin With 25-hydroxyvitamin D3 App 20130252927 - Krammer-Lukas; Stephanie ; et al.	2013-09-26
Treating Hyperglycemia With 25-hydroxyvitamin D3 App 20130210782 - Buck; Neil Robert ; et al.	2013-08-15
Use Of 25-hydroxy-vitamin D3 To Affect Human Muscle Physiology App 20130150598 - BUCK; Neil Robert ; et al.	2013-06-13
Trigonelline As A Muscle Stimulant App 20130018076 - FRIEDEL; Angelika ; et al.	2013-01-17
Trigonelline as a muscle stimulant Grant 8,323,707 - Friedel , et al. December 4, 2	2012-12-04
Use of phthalide derivatives for the treatment of type 2 diabetes mellitus Grant 8,242,168 - D'Orazio , et al. August 14, 2	2012-08-14
Combination Of Vitamin D And 25-hydroxyvitamin D 3 App 20120196057 - Buck; Neil Robert ; et al.	2012-08-02
Niacin And/or Trigonelline As A Muscle Stimulant App 20120190617 - Friedel; Angelika ; et al.	2012-07-26
Compositions comprising epigallocatechin gallate and protein hydrolysate Grant 8,129,337 - Wolfram March 6, 2	2012-03-06
Cajanus Extracts And Glucosamine For Inflammatory Disorders App 20110300240 - Raederstorff; Daniel ; et al.	2011-12-08
Rosehip Powder Having Small Particle Size App 20110262612 - Gotz; Nicolle ; et al.	2011-10-27
Trigonelline As A Muscle Stimulant App 20110142974 - Friedel; Angelika ; et al.	2011-06-16
Treating Hypertension With 25-hydroxyvitamin D3 App 20110118218 - Buck; Neil Robert ; et al.	2011-05-19
Combination Of Vitamin D And 25-hydroxyvitamin D 3 App 20110052707 - Buck; Neil Robert ; et al.	2011-03-03
Treating Hyperglycemia With 25-hydroxyvitamin D3 App 20110039811 - Buck; Neil Robert ; et al.	2011-02-17
Combined Use Of 25-hydroxy-vitamin D3 And Vitamin D3 For Improving Bone Mineral Density And For Treating Osteoporisis App 20110039809 - Buck; Neil Robert ; et al.	2011-02-17
Use Of 25-hydroxy-vitamin D3 To Affect Human Muscle Physiology App 20110039810 - Buck; Neil Robert ; et al.	2011-02-17
Novel Use Of (-)-epigallocatechin Gallate App 20100113584 - Raederstorff; Daniel ; et al.	2010-05-06
Compositions for the treatment and prevention of diabetes mellitus Grant 7,691,420 - Raederstorff , et al. April 6, 2	2010-04-06
Novel Use Of Organic Compounds App 20100041746 - D'Orazio; Daniel ; et al.	2010-02-18
Novel Nutraceutical Compositions App 20090305945 - Wolfram; Swen ; et al.	2009-12-10
Novel Use of Organic Compounds App 20090239944 - D'orazio; Daniel ; et al.	2009-09-24
Novel Use Of Organic Compounds App 20090221693 - D'Orazio; Daniel ; et al.	2009-09-03
Nutraceutical compositions comprising epigallocatechin gallate and raspberry ketone App 20090221694 - Raederstorff; Daniel ; et al.	2009-09-03
Compounds for the Treatment of Non-Autoimmune Type 2 Diabetes Mellitus and/or Syndrome X App 20090203773 - D'Orazio; Daniel ; et al.	2009-08-13
Use Of Phthalide Derivatives For The Treatment And Prevention Of Diabetes Mellitus App 20090192218 - D'Orazio; Daniel ; et al.	2009-07-30
Novel use of nutraceutical compositions App 20090163579 - Raederstorff; Daniel ; et al.	2009-06-25
Compositions comprising tripeptides inhibiting ace App 20090143311 - Edens; Luppo ; et al.	2009-06-04
Novel Nutraceutical Compositions App 20090131331 - Edens; Luppo ; et al.	2009-05-21
Novel Use of Nutraceutical Compositions Comprising Resveratrol App 20080262081 - Raederstorff; Daniel ; et al.	2008-10-23
Novel Composition Comprising Ligustilide and Process For Their Manufacture App 20080152730 - Proplesch; Ralf ; et al.	2008-06-26
Compositions Comprising Epigallocatechin Gallate and Protein Hydrolysate App 20080119389 - Wolfram; Swen	2008-05-22
Novel Nutraceutical Compositions App 20080075828 - Wolfram; Swen ; et al.	2008-03-27
Use of phthalide derivatives for the treatment and prevention of diabetes mellitus App 20070082947 - D'Orazio; Daniel ; et al.	2007-04-12
Compositions for the treatment and prevention of diabetes mellitus App 20070042057 - Raederstorff; Daniel ; et al.	2007-02-22
Nutraceutical compositions comprising epigallocatechin gallate and raspberry ketone App 20050288360 - Raederstorff, Daniel ; et al.	2005-12-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.